Birdwatch Note
2022-09-03 21:01:39 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Many large high quality trials have tested ivermectin as a treatment for COVID. These trials have consistently found that ivermectin is NOT beneficial in people with COVID. See this meta-analysis by the Cochrane group (considered the gold standard in evidence based medicine): https://www.cochrane.org/CD015017/INFECTN_ivermectin-preventing-and-treating-covid-19
Written by B3DCDF701CB31021D92F2A1BB97A94EF
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1566041186581757953
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1566169577574526976
- noteId - 1566169577574526976
- participantId - B3DCDF701CB31021D92F2A1BB97A94EF
- noteAuthorParticipantId -
- createdAtMillis - 1662238899975
- tweetId - 1566041186581757953
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - CHALLENGING
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Many large high quality trials have tested ivermectin as a treatment for COVID. These trials have consistently found that ivermectin is NOT beneficial in people with COVID. See this meta-analysis by the Cochrane group (considered the gold standard in evidence based medicine): https://www.cochrane.org/CD015017/INFECTN_ivermectin-preventing-and-treating-covid-19
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2022-09-03 21:01:39 UTC (1662238899975) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
B9AB08E88D622E9E3DB347E0F2670AD2B9489533BA584375FABC6964845EC889 | ||
| 2022-09-03 21:01:39 UTC (1662238899975) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
B3DCDF701CB31021D92F2A1BB97A94EF |
Note Ratings
| rated at | rated by | |
| 2022-09-03 17:02:35 -0500 | 05D21768BC18D425A7EE4E6F80F71CF3 | Rating Details |
| 2022-09-03 19:42:29 -0500 | 0AB689C453F1E569091558B03440721F | Rating Details |
| 2022-09-07 19:12:11 -0500 | 0C91900F7892D8DA899BB85193A8758A | Rating Details |
| 2022-09-05 05:00:25 -0500 | 152C664EC474246EB3D5BD53CBEFF1A9 | Rating Details |
| 2022-09-05 11:12:40 -0500 | 38F3548DB0968885447F4DB82116D4277DCAC84BCA00434FF4A2AF27332D007E | Rating Details |
| 2022-09-03 18:58:53 -0500 | 40625ACC55AFE31D886B21316D26C93A | Rating Details |
| 2022-09-03 20:08:41 -0500 | 46D893DFC474111C12B5EF54ADED5291021E07B5BC4D944EB4F35D18A93785C7 | Rating Details |
| 2022-09-04 16:31:03 -0500 | 476EF2160C8C074290885FB7EF345771 | Rating Details |
| 2022-09-03 22:30:12 -0500 | 47AD3BD4ED0E64C9EA74DB3A322FA6AA5E5F8D84E57A6E405CC624F53C571EC8 | Rating Details |
| 2022-09-03 17:35:38 -0500 | 47CE75076B4EC5B451241F22FB56FBE6 | Rating Details |
| 2022-09-04 06:56:50 -0500 | 491F86E495D57AD373CE546FA4D9E4C79AB3B56F4BD9907D2CD96BB4578540B1 | Rating Details |
| 2022-09-04 08:01:04 -0500 | 4D971DD119DA920463DF54524736E0A6 | Rating Details |
| 2022-09-03 20:46:57 -0500 | 51CF24E741A18508E181F80408E6E7E109FDDE98B31A9F11F05480731FF485A6 | Rating Details |
| 2022-09-04 21:14:48 -0500 | 58DCC3177CBF76252BC95E45E1CDCEDD949A78D0F82BD8178D49913D8726326B | Rating Details |
| 2022-09-03 20:46:57 -0500 | 5AD0B5581E4AC4683F4A8D75DEB62680 | Rating Details |
| 2022-09-04 11:59:01 -0500 | 6C4D39819380C974F26A34B6C85405BD | Rating Details |
| 2022-09-03 17:02:35 -0500 | 6CB264946CF4A055FE26B8B4AFD5EFEF7F8B473647347685838E81DB6B160AAA | Rating Details |
| 2022-09-04 08:01:04 -0500 | 6D52E77119FC0A73F40D1C068C5E67531E16FA62CA9EF821895346168DDF9704 | Rating Details |
| 2022-09-04 19:17:18 -0500 | 71A49EE665957BB16D06E6E5008DA7ECF77E9835F05402A54A630965DD88545E | Rating Details |
| 2022-09-04 09:00:10 -0500 | 74E1E52EE8EB5E15EA1F55CF08E962E04EEFFEFB76C3E3817BF85EC664EB959B | Rating Details |
| 2022-09-03 22:15:14 -0500 | 9439A1BE03E471B9F7026843AC7E7A4E | Rating Details |
| 2022-09-03 22:30:12 -0500 | 9795BF8962792425EFA8D2F4F92685B4 | Rating Details |
| 2022-09-04 11:59:01 -0500 | 9FDF9893DFAB4D45202E6558FAE3342DA24DFA5D58A9F7C14A2CF2DD79A3E176 | Rating Details |
| 2022-09-06 21:20:21 -0500 | A0CF3B7AE24A4AF95E88D6060D21C913CD15746D8E39F440DE56B07898E3813C | Rating Details |
| 2022-09-05 05:00:25 -0500 | A227869B752DF62F7538C29F2D2D225BAE499F3095FF33A985D81DD1C622A0E8 | Rating Details |
| 2022-09-07 19:12:11 -0500 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
| 2022-09-03 19:42:29 -0500 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
| 2022-09-03 17:35:38 -0500 | A8E19E20F2050BF3998242D88A5027E40DB258939006E09D57269202FD25B7CB | Rating Details |
| 2022-09-05 11:12:40 -0500 | AC5368A3F99A3EA105D5DE64E5F3BF1D | Rating Details |
| 2022-09-04 09:00:10 -0500 | AEFCDB949A0D44C0F7CFEB190DED5F1B | Rating Details |
| 2022-09-06 21:20:21 -0500 | B03233DBE3F9745B3FB33525898BBDE6 | Rating Details |
| 2022-09-03 22:15:14 -0500 | B58FC591E8C96DE13676245FFD327D1A6F48B39F0D4D0298B1C0B07D02B268FD | Rating Details |
| 2022-09-03 18:58:53 -0500 | C2C2E6523C841E4558B4DD193A51D198D6ADF28E86F47674D7FA108D07A1CE9E | Rating Details |
| 2022-09-04 21:14:48 -0500 | CD1F35016A8816108987739EEC9C84B9 | Rating Details |
| 2022-09-04 06:56:50 -0500 | CD9D49DCCCDDE369B34482B66E49E224 | Rating Details |
| 2022-09-04 19:17:18 -0500 | D4E9594EC751DEEE7D67FE95734D9AD0 | Rating Details |
| 2022-09-03 20:08:41 -0500 | DB835EE09E208271F1AE42AA00D8490D | Rating Details |
| 2022-09-04 16:31:03 -0500 | ECF10856E739FB7FC1EE8DF7E08EE986B956A1D3F35ABDEEACA52B4923E65C29 | Rating Details |
| 2022-09-03 20:08:41 -0500 | Rating Details | |
| 2022-09-03 22:15:14 -0500 | Rating Details | |
| 2022-09-04 19:17:18 -0500 | Rating Details | |
| 2022-09-05 05:00:25 -0500 | Rating Details | |
| 2022-09-03 19:42:29 -0500 | Rating Details | |
| 2022-09-04 08:01:04 -0500 | Rating Details | |
| 2022-09-04 06:56:50 -0500 | Rating Details | |
| 2022-09-05 11:12:40 -0500 | Rating Details | |
| 2022-09-04 11:59:01 -0500 | Rating Details | |
| 2022-09-03 17:02:35 -0500 | Rating Details | |
| 2022-09-04 09:00:10 -0500 | Rating Details | |
| 2022-09-06 21:20:21 -0500 | Rating Details | |
| 2022-09-03 17:35:38 -0500 | Rating Details | |
| 2022-09-07 19:12:11 -0500 | Rating Details | |
| 2022-09-03 20:46:57 -0500 | Rating Details | |
| 2022-09-03 18:58:53 -0500 | Rating Details | |
| 2022-09-04 16:31:03 -0500 | Rating Details | |
| 2022-09-03 22:30:12 -0500 | Rating Details |